Tumor angiogenesis was abrogated by the specific knockdown of intrinsic VASH2 in ovarian cancer cells, which inhibited tumor growth, peritoneal dissemination, and ascites production.12 This evidence concerns the gene VASH2 and ovarian carcinoma.